iSpecimen Inc. (ISPC)

0.2759 +0.0069 (+2.57%) As of 09:33AM EDT. Market open.

iSpecimen Inc.

450 Bedford Street
Lexington, MA 02420
United States
781 301 6700
https://ispecimen.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 53

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Tracy Wilson Curley	CEO, CFO, Treasurer & Director	437.5k	N/A	1962
Mr. Benjamin Bielak	Chief Information Officer & Secretary	391.2k	N/A	1970
Ms. Carly Lejnieks	Vice President of Marketing	N/A	N/A	N/A
Ms. Annette Arnold	Vice President of Sales & Business Development	N/A	N/A	N/A
Mr. David Wages M.D., Ph.D.	Chief Medical Officer	N/A	N/A	N/A
Mr. Eric Langlois	Chief Revenue Officer	N/A	N/A	N/A
Mr. Evan Cox	Senior Vice President of Strategy & Innovation	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Corporate governance

iSpecimen Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.